For investing here.
Advanced Cell is the "Microsoft" of the regenerative medicine age which is now un-folding right before our very eyes!
Exciting time are coming! Fortunes are going to be made over the coming months. DOn't be one of those who has to go thru life saying, " I should have never sold that stock!" That would be a tragedy not only for you,, but your heirs as well.
This is NO PIPE DREAM,, this science is real, and it is about to change the world as we know it.
Advanced Cell is leading the way - and you are VERY LUCKY to know about it this early in the game!
WHen, and this is a when that is not to far off now,,, WHen ACTC can market their AMD cure,, When they can Market their Heart Treatments, WHen they can start marketing their MASS PRODUCTION of human blood,, what will the share price be then,,,???
What about when they reverse aging?? What will the share price be then?
WHat about when they star production of human organs for transplant? WHat will their share price be then?
We ,, lets see,, remember Qualcom,, they provided a ne wform of communication, the internet,, and were only one on MANY players,,, Their stock price shot up to $1500/share.
When ACTC realizes it's potential share prices $1000.00 $3000.000 $5000.000 all possible!!
This is the potential we face being among the first to bring this technology to the market,,., and we will do it,, we are doing it NOW,,,
When will all this happen??? It's all starting in about 3-6 weeks from now with the first injections..
Due to the "EXPONENTIAL" growth curve we now appear to be on,, we should see this all un-fold in the next 5-6 years!
I expect to be several thousand years old,,,
Yeah, Yeah Yeah,,, chuckle away,,,
I and my fellow LONGS will be chuckling the longest.
Good Profits to you all!!
Al the Profit
I owned Qualcomm and I have that same giddy feeling that I had 12 yrs ago.My $5000 investment turned into $200K in 2yrs.This stock is giving me that same feeling. Im expecting great things, but it's going to be hard to stay long. I shouldve sold my Qcom at $800 but stayed in and that ended up hurting me when the market crashed in 2000.
Other Biotech Companies.
EBITDA $726 million
Market Cap $$18.1 million
EBITDA $6.7 million
Market Cap $53.5 million
Where will ACTC be with just AMD treatment. 2,000,000 treatments/yr $10,000/treatment.
That's $20 billion/yr revenue. What's the EBITDA/treatment $3,000.
Thats $6 billion EBITDA. Why can't we be the next AMGEN. Market Cap $53 billion.
ACTC 's current market cap $.2 billion. That would mean the stock price should go up too around $47/share with the same market cap as AMGEN
This is just with the AMD treatment.
One thing about this trial we will know pretty quickly if it works or not.
If it works the doors will come off and it will be like a torando hit this company.
lets look bigger if ACTC lands a big pharm partner for RPE
LETS SAY 35 million upfront including paying all costs for trials
with milestones of 50 to 100 million total deal 300 to 500 million
Now step back ACTC only has 900 thousand debt low overhead. Lanza
can now explore cures for other diseases check out other markets
per their website
i am not saying anything out of this world the RPE program is 30 billion dollar market for dry AMD no known cure what is that worth
to big pharm.
jdevine42: according to your post history, your not the sharpest tool in the shed, are you? http://search.messages.yahoo.com/search?.mbintl=finance&q=jdevine42&action=Search&r=Huiz75WdCYfD_KCA2Dc-&within=author&within=tm